CXCL10 and cervical cancer: Moreover, a general HDAC inhibitor, similar to SCFAs, also reduced CXCL10 release by IFN-γ-activated human colonic subepithelial myofibroblasts and cervical cancer cells (HeLa cells) and 2fTGH cells [38,48,53].